000 | 01220 a2200325 4500 | ||
---|---|---|---|
005 | 20250516224102.0 | ||
264 | 0 | _c20161107 | |
008 | 201611s 0 0 eng d | ||
022 | _a1601-0825 | ||
024 | 7 |
_a10.1111/odi.12275 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAhmad, F | |
245 | 0 | 0 |
_aCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets. _h[electronic resource] |
260 |
_bOral diseases _cJan 2015 |
||
300 |
_ae25-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 |
_a3',5'-Cyclic-GMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aMurata, T | |
700 | 1 | _aShimizu, K | |
700 | 1 | _aDegerman, E | |
700 | 1 | _aMaurice, D | |
700 | 1 | _aManganiello, V | |
773 | 0 |
_tOral diseases _gvol. 21 _gno. 1 _gp. e25-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/odi.12275 _zAvailable from publisher's website |
999 |
_c24037699 _d24037699 |